Navigation Links
LIATEST AT III

ProductsLIATEST AT III
Company Diagnostica Stago, Inc.
Item LIATEST AT III
Features 
Description Immuno-turbidimetric Assay for Antithrombin III Antigen. Suspension of microlatex particles coated with specific antibodies.
Info Diagnostica Stago, Inc.
Customer Service: (800) 222-COAG
Web site: http://www.stago-us.com/

Related medicine products :

1. STA LIATEST CONTROL N + P
2. STA LIATEST VWF
3. STA LIATEST FREE PROTEIN S
4. LIATEST PROTEIN S
5. STA LIATEST D-DI
TAG: LIATEST III
(Date:12/6/2009)... Blood clotting, or coagulation, is an important process ... is injured. Sometimes, however, clots form on the ... do not dissolve naturally, a potentially life-threatening situation ... Annual Meeting of the American Society of Hematology ... aspirin and heparin with the hope of preventing ...
(Date:12/6/2009)... says dangerous substances such as asbestos have been found in toys ... ... (PRWEB) December 6, 2009 -- As parents shop for children,s toys ... recalls due to lead paint or asbestos contamination, says a New ... emergency rooms each year due to toy-related injuries,” says Joseph W. ...
(Date:12/5/2009)... South Africa, December 5 The first Football,for ... Cape Town opened its doors,today (5 December 2009). ... Cape Premier Helen Zille, 2010 FIFA World Cup ... African Football Association,President Kirsten Nematandani and Executive Mayor ...
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor ... the knot, since research has shown that never-married adults have ... something wrong with those who go it alone anyway? , ... measures shows that never-married people aged 40 and up can ...
(Date:12/5/2009)... up in the most unusual places, and to do everything from growing ... ... 5, 2009 -- Who would have thought that your wine, water and ... Texas has announced a new line of turbines, for industry end users, ...
Breaking Medicine News(10 mins):Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3
... is better than using one to stage lung cancer, and ... surgical method now most commonly used, researchers at Mayo Clinic ... the Journal of the American Medical Association. , This new ... is inserted into a patients esophagus to access lymph nodes ...
... ATRC ), a medical device company and a ... results for the fourth,quarter and full year ended December ... host a conference call at 10:00 a.m. ET on ... year 2007 results. A,live web cast of the conference ...
... Dr. Azimi offers total dental makeover to downtown Las Vegan, ... Americans, you,think extreme smile makeovers are for celebrities and the ... Las Vegas, downtown,general and cosmetic dentist, has reserved the dental ... For the first time, Dr. Azimi has agreed to donate ...
... adverse events for heart patients is in early period , , ... the first three months after heart patients stop taking the ... the first study to make this observation," said Dr. P. ... and lead author of a report in the Feb. 6 ...
... The MayaTech Corporation, a,leading provider of ... expanded its services with the establishment of ... center will study the,legal, regulatory, ethical, and ... "MayaTech recognizes that nanotechnology offers exciting,possibilities," says ...
... There is a lack of equity in health care ... in a nationwide survey and analyzed by a UT ... available online and published as an abstract in the ... certain disparities are particularly pronounced for specific racial and ...
Other Medicine News:Health News:Researchers find less invasive, highly accurate methods 2Health News:Researchers find less invasive, highly accurate methods 3Health News:Researchers find less invasive, highly accurate methods 4Health News:AtriCure Announces Web Cast and Conference Call of Fourth Quarter and Full Year 2007 Financial Results 2Health News:A Downtown Las Vegas Dental Makeover by Dr. Azimi for the Most Deserving Resident or Working Professional 2Health News:First 90 Days After Stopping Plavix Most Dangerous 2Health News:MayaTech Establishes Center to Focus on Breakthrough Technology 2Health News:National survey shows minority children experience multiple disparities in health care 2
(Date:12/4/2009)... Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC ... and Trademark Office has allowed its patent application on ... the manufacture of the Company,s DCVax® therapeutic cancer vaccines. ... very high concentration of dendritic cells (which are the ...
(Date:12/4/2009)... N.J., Dec. 4 Depression, anxiety disorder, bipolar ... and migraine: These are among the comorbidities reported ... they had been diagnosed with epilepsy versus those ... of approximately 173,000 households across the U.S. ,, ...
(Date:12/3/2009)... ACTON, Mass., Dec. 3 Allen Medical Systems, a ... ), today announced the launch of its new Allen ... www.AllenAmatech.com . ,, The website reinforces the ... of the new product catalog, with detailed descriptions and ...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Evolvent Awarded Health Information Exchange Contract 13638 1Evolvent Awarded Health Information Exchange Contract 13638 2Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 1Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 2Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 3LSTM to lead EU project to coordinate antimalarial drug research 54952 1LSTM to lead EU project to coordinate antimalarial drug research 54952 2